Read the Journal of Managed Care + Specialty Pharmacy (JMCP) May 2025 Issue
AMCP Sends Letter of Concern for Needed Provisions in Senate Amendment for H.R. 6
The Academy of Managed Care Pharmacy (AMCP) is writing in strong support of the “Opioid Crisis Response Act”. The importance of this Act increases as the number of overdose deaths according to the CDC rise (72,000 overdose deaths in 2017).1 As you know, the Act will advance patient treatment and recovery initiatives, improve prevention of opioid addiction, protect communities, and bolster efforts to fight deadly illicit synthetic drugs like fentanyl.
Related
AMCP is your partner in navigating AI’s transformative potential—ensuring patient-centered, ethically sound, and strategically aligned implementation across pharmacy practice and policy.
Retinal diseases in patients with diabetes pose signi cant challenges for health care systems. With a high treatment burden and advances in durable therapies, managed care organizations can optimize patient care by addressing coverage barriers that impact timely treatment with anti-VEGF therapies. This roadmap outlines essential points to better retinal disease management and improve treatment for populations of patients with diabetes at high risk for blindness.
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
